. "Appendix C: Putting Addiction Treatment Medications to Use: Lessons Learned." New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions
Lowinson, J.H., Payte, J.T., Joseph, H., Marion, I.J., and Dole, V.P. (1992). Methadone maintenance. In J.H. Lowinson, P. Ruiz, R.B. Millman, and J.G. Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 405-414). Philadelphia: Williams and Wilkins.
Martin, S.S., Butzin, C.A., Saum, C.A., and Inciardi, J.A. (1999). Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: From prison to work release to aftercare. Prison Journal,79(3), 294-320.
McFarland, B.H., Lierman, W.K., Penner, N.R., McCamant, L.E., and Zani, B.G. (2003). Employee benefits managers’ opinions about addiction treatment. Journal of Addictive Diseases,22(2), 15-29.
McLellan, A.T., Arndt, I.O., Metzger, D.S., Woody, G.E., and O’Brien, C.P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association,269(15), 1953-1959.
McLellan, A.T., O’Brien, C.P., Lewis, D., and Kleber, H.D. (2000). Drug addiction as a chronic medical illness: Implications for treatment, insurance and evaluation. Journal of the American Medical Association,284(13), 1689-1695.
Metzger, D.S., Navaline, H., and Woody, G.E. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports,113(Suppl 1), 97-106.
Morris, P.L., Hopwood, M., Whelan G., Gardiner, J., and Drummond, E. (2001). Naltrexone for alcohol dependence: A randomized controlled trial. Addiction,96(11), 1565-1573.
National Institutes of Health Consensus Conference. (1998). Effective medical treatment of opiate addiction. Journal of the American Medical Association,280(22), 1936-1943.
Oslin, D.W., Berrettini, W., Kranzler, H.R., Penninati, H., Gelernter, J., Volpicelli, J.R., and O’Brien, C.P. (2003). A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology,28(8), 1546-1552.
Peters, R.H., May, R.I., and Kearns, W.D. (1992). Drug treatment in jails: Results of a nationwide survey. Journal of Criminal Justice,20, 283-295.
Resnick, R.B., Washton, A.M., and Stone-Washton, N. (1981). Psychotherapy and naltrexone in opioid dependence. In L.S. Harris (Ed.), Problems of drug dependence (pp. 109-115). Rockville, MD: U.S. Department of Health and Human Services.
Shichor, D., and Sechrest, D. (2001). Introduction: Special issue on drug courts. Journal of Drug Issues,31, 1-6.
Shoptaw, S., Frosch, D.L., Rawson, R.A., and Ling, W. (1997). Cocaine abuse counseling as HIV prevention. AIDS Education and Prevention,9(6), 511-520.
Woody, G.E., Gallop, R., Luborsky, L., Blaine, J., Frank, A., Gastfriend, D., Crits-Christoph, P., and the Cocaine Psychotherapy Study Group. (2003). HIV risk reduction in the NIDA cocaine psychotherapy study. Journal of Acquired Immune Deficiency Syndromes,33(1), 82-87.